Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
781.50
790.20
799.50
798.60
794.40
735.90
748.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
781.50
790.20
799.50
798.60
794.40
735.90
748.90
Raw Material Cost
133.40
103.40
100.90
87.60
92.50
75.90
83.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.00
3.10
3.00
7.30
6.10
7.90
10.10
Selling and Distribution Expenses
184.10
189.80
181.80
190.80
170.10
168.50
219.20
Other Expenses
13.52
13.64
12.45
12.67
14.29
12.59
9.34
Total Expenditure (Excl Depreciation)
455.70
432.70
410.20
412.40
411.60
378.20
405.80
Operating Profit (PBDIT) excl Other Income
325.79999999999995
357.5
389.3
386.2
382.8
357.70000000000005
343.1
Other Income
-66.10
43.90
46.70
55.20
46.80
46.70
55.60
Operating Profit (PBDIT)
282.30
424.20
457.90
462.50
449.40
424.10
417.80
Interest
3.00
3.10
3.00
7.30
6.10
7.90
10.10
Exceptional Items
61.60
45.70
5.00
-25.70
0.00
0.00
0.00
Gross Profit (PBDT)
648.10
686.80
698.60
711.00
701.90
660.00
665.80
Depreciation
22.60
22.80
21.90
21.10
19.80
19.70
19.10
Profit Before Tax
318.30
444.00
438.00
408.40
423.50
396.50
388.60
Tax
43.40
79.70
99.30
98.90
101.30
95.20
79.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
274.90
364.30
338.70
309.50
322.20
301.30
309.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
274.90
364.30
338.70
309.50
322.20
301.30
309.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
274.90
364.30
338.70
309.50
322.20
301.30
309.10
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
5,901.10
7,096.20
6,590.20
7,173.60
6,807.20
6,444.00
6,100.90
Earnings per share (EPS)
5.82
7.7
7.16
6.41
6.63
6.19
6.39
Diluted Earnings per share
5.82
7.7
7.16
6.41
6.63
6.19
6.39
Operating Profit Margin (Excl OI)
41.69%
45.24%
48.69%
48.36%
48.19%
48.61%
45.81%
Gross Profit Margin
43.62%
59.07%
57.52%
53.78%
55.8%
56.56%
54.44%
PAT Margin
35.18%
46.1%
42.36%
38.76%
40.56%
40.94%
41.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -1.10% vs -1.16% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -24.54% vs 7.56% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -8.39% vs -7.51% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -3.23% vs 3.33% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of United Therapeutics Corp. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
781.50
814.50
-33.00
-4.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
781.50
814.50
-33.00
-4.05%
Raw Material Cost
133.40
13.80
119.60
866.67%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.00
0.00
3.00
Selling and Distribution Expenses
184.10
318.50
-134.40
-42.20%
Other Expenses
13.52
29.62
-16.10
-54.36%
Total Expenditure (Excl Depreciation)
455.70
628.50
-172.80
-27.49%
Operating Profit (PBDIT) excl Other Income
325.80
186.00
139.80
75.16%
Other Income
-66.10
56.70
-122.80
-216.58%
Operating Profit (PBDIT)
282.30
250.00
32.30
12.92%
Interest
3.00
0.00
3.00
Exceptional Items
61.60
4.10
57.50
1,402.44%
Gross Profit (PBDT)
648.10
800.70
-152.60
-19.06%
Depreciation
22.60
7.30
15.30
209.59%
Profit Before Tax
318.30
246.80
71.50
28.97%
Tax
43.40
48.90
-5.50
-11.25%
Provisions and contingencies
0
0
0.00
Profit After Tax
274.90
197.90
77.00
38.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
274.90
197.90
77.00
38.91%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
274.90
197.90
77.00
38.91%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
5,901.10
3,407.40
2,493.70
73.18%
Earnings per share (EPS)
5.82
1.91
3.91
204.71%
Diluted Earnings per share
5.82
1.91
3.91
204.71%
Operating Profit Margin (Excl OI)
41.69%
22.84%
0.00
18.85%
Gross Profit Margin
43.62%
31.20%
0.00
12.42%
PAT Margin
35.18%
24.30%
0.00
10.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 78.15 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -1.10% vs -1.16% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -1.62% vs 17.22% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 27.49 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -24.54% vs 7.56% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -14.68% vs 5.09% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 34.84 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -8.39% vs -7.51% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -13.46% vs 8.43% in Mar 2025
Quarterly - Interest
Interest 0.30 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -3.23% vs 3.33% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -50.82% vs -54.14% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 41.69%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
